Myriad Appeals Decision Invalidating BRCA Patents

Myriad Genetics and the University of Utah Research Foundation are appealing a decision rendered in March that found that the company's BRCA gene patents are "unpatentable."

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.